诺塞博假说 非发作的认知行为疗法 (NH-CBT):一个连续的病例系列
Matt Richardson1, Michael Cathro1, Maria Kleinstäuber1,2
1Department of Psychological Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
Behavioural and cognitive psychotherapy
|November 29, 2023
概括
诺塞博假设 认知行为疗法 (NH-CBT) 在一系列病例中有效减少了非发作. 大多数参与者实现了发作自由,证明了NH-CBT.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 精神病体医学是一种精神病体医学.
背景情况:
- 功能神经症状障碍 (FNSD) 通常与预测编码模型相关.
- 诺塞博假设认知行为疗法 (NH-CBT) 已显示FNSD运动症状的缓解率很高.
- NH-CBT涉及通过nocebo效应和改变信念的身体活动透明地解释症状因果关系.
研究的目的:
- 评估NH-CBT在减少或消除非发作 (NES) 的有效性.
- 探索NES作为FNSD的潜在亚型,可用NH-CBT治疗.
主要方法:
- 使用了一个连续的案例系列设计.
- 十名参与者在12周的治疗期间接受了NH-CBT.
- 主要结局:发作频率;次要结局:各种临床测量和定性访谈.
主要成果:
- 10名参与者中有7人通过治疗后评估实现了无性发作.
- 所有没有发作的参与者都保持了至少5个月的缓解.
- 六名参与者在6个月的随访期间仍然没有发作,对二次措施的效果大.
结论:
- 这一案例系列表明NH-CBT可用于治疗非发作.
- NH-CBT显示可能有助于减少NES患者的发作频率.
- 需要进一步的研究来证实这些初步发现.
相关概念视频
Seizures: Classification
373
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
373
Electroconvulsive Therapy
44
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
44
Arteries of the Lower Limbs
192
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
192
Antiepileptic Drugs: Glutamate Antagonists
376
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
376
Antiepileptic Drugs: GABAergic Pathway Potentiators
414
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
414


